Simplify Asset Management Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 49.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,372 shares of the healthcare conglomerate’s stock after acquiring an additional 6,772 shares during the period. UnitedHealth Group accounts for approximately 0.6% of Simplify Asset Management Inc.’s holdings, making the stock its 17th biggest holding. Simplify Asset Management Inc.’s holdings in UnitedHealth Group were worth $11,911,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the period. West Financial Advisors LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $32,000. Finally, Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group in the second quarter worth about $31,000. 87.86% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on UNH shares. Stephens reduced their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Barclays decreased their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, UBS Group cut their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.
UnitedHealth Group Trading Down 0.2 %
Shares of UNH traded down $0.99 during midday trading on Friday, hitting $592.16. The stock had a trading volume of 783,950 shares, compared to its average volume of 3,876,646. The stock’s 50 day moving average is $582.95 and its 200 day moving average is $548.34. The firm has a market cap of $544.95 billion, a PE ratio of 38.72, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.56 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s payout ratio is 54.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Comparing and Trading High PE Ratio Stocks
- Top-Performing Non-Leveraged ETFs This Year
- How to Plot Fibonacci Price Inflection Levels
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- CD Calculator: Certificate of Deposit Calculator
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.